摘要
目的探讨研究丙型肝炎病毒E2蛋白的生物学特征。方法从NCBI数据库中获取丙型肝炎病毒E2蛋白氨基酸序列,利用在线分析软件分析其生物学特征,包括分子式、半衰期、疏水性、跨膜区、信号肽,磷酸化位点、二级结构特征等,通过综合分析丙型肝炎病毒E2蛋白的各类性质,得到最佳抗原表位区域,并对丙型肝炎病毒E2蛋白氨基酸序列预测结果进行了比对分析。结果丙肝病毒E2蛋白由344个氨基酸组成,分子式为C1696H2543N463O490S21,不稳定系数为35.6,理论等电点为7.2,总体平均亲水性为-0.131,为稳定性亲水蛋白质,E2蛋白二级结构中主要成分为无规则卷曲(占比43.6%)。该蛋白无信号肽且无跨膜区,约存在50个磷酸化位点,最佳抗原区域位于95-100氨基酸位置。结论生物信息学方法预测丙型肝炎病毒E2蛋白属于稳定性亲水蛋白,含有抗原表位区域,可为丙型肝炎表位疫苗的研制提供参考依据。
Objective Analyzing sequence characteristics of E2 protein in Hepatitis C Virus(HCV)were studied via bioinformatics tools.Methods The hepatitis C virus E2 protein amino acid sequence was obtained from the National Center for Biotechnology Information(NCBI)database.The online analysis software was used to analyze and study the sequence characteristics of hepatitis C virus E2 protein.The basic information analysis included molecular formula,half-life,hydrophobicity,transmembrane region,and signal peptide.Functional information analysis included phosphorylation sites and secondary structure characteristics.Finally,a comprehensive analysis of the various properties of the hepatitis C virus E2 protein was done to obtain the best epitope region,and the analysis of the above-mentioned prediction results of the amino acid sequence characteristics of the hepatitis C virus E2 protein were compared.Results E2 protein in Hepatitis C Virus consists of 344 amino acids,its molecular formula is C1696 H2543 N463 O490 S21,and the instability coefficient is 35.6.The protein is predicted to be a stable protein,the theoretical isoelectric point is 7.20,and the total average hydrophilicity is-0.131,which denotes that the E2 protein is a hydrophilic protein.The main component of the secondary structure is irregularly coiled(43.6%),the protein has no signal peptide,and no transmembrane region,50 phosphorylation sites.Conclusion Best antigenic epitope formation area was determined via a comprehensive analysis of the availability of E2 protein in HCV,βturn angle,antigenicity and hydrophobicity,etc.The study of E2 protein in HCV provides reference for the development of an epitope vaccine against HCV.
作者
李滚
张甜甜
李蓓
张涛
卢香香
LI Gun;ZHANG Tian-tian;LI Bei;ZHANG Tao;LU Xiang-xiang(Department of Biomedical Engi-neering,School of Electronic In formation Engineering,XiAn Technological University,XiAn 710021,China)
出处
《中国病原生物学杂志》
CSCD
北大核心
2019年第5期511-514,共4页
Journal of Pathogen Biology
基金
陕西省教育厅专项科学研究计划项目(No.18JK0377)